FH and hereditary leiomyomatosis and renal cell cancer: Because the case presented herein with cutaneous mosaicism has a germline FH mutation, she has the same risk of developing type II papillary renal cell carcinoma as an individual with HLRCC who presents without cutaneous mosaicism.